MarketCap
Neogen Corporation NEOG
$ 11.67
-3.39%
Facebook
X
Telegram
Country |
 USA |
IPO year |
1989 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
218 M |
Market Cap[1] |
$ 2.54 B |
EBITDA (LTM) |
$ 94.7 M |
P/E (LTM) |
-38.933333 |
P/S (LTM) |
2.914031 |
EPS (LTM) |
-0.3 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Interpace Biosciences
IDXG
|
$ 7.0 | -13.43 % | $ 31 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 204.62 | -1.43 % | $ 16 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Co-Diagnostics
CODX
|
$ 0.29 | -9.5 % | $ 386 K | Nasdaq Capital Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 13.19 | 6.46 % | $ 135 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 2.37 | 15.05 % | $ 9.44 M | Nasdaq Capital Market |  Israel |
 |
Myriad Genetics
MYGN
|
$ 5.66 | -1.39 % | $ 524 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.78 | -1.24 % | $ 3.76 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
$ 50.52 | -0.07 % | $ 11 B | NYSE |  Niderland |
 |
NeoGenomics
NEO
|
$ 16.97 | -3.58 % | $ 2.17 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.71 | 0.58 % | $ 1.28 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.22 | -5.93 % | $ 666 M | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 23.56 | 6.13 % | $ 37.8 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 15.9 | -0.31 % | $ 1.42 B | Nasdaq Global Select Market | USA |
 |
Sotera Health Company
SHC
|
$ 16.25 | -1.16 % | $ 4.61 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 11.56 | -4.43 % | $ 487 M | Nasdaq Global Select Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Trinity Biotech plc
TRIB
|
$ 5.88 | 10.08 % | $ 2.11 B | Nasdaq Global Select Market | Irlanda |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 26.91 | 0.9 % | $ 602 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 132.17 | -2.35 % | $ 7.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Waters Corporation
WAT
|
$ 476.29 | -0.09 % | $ 28.4 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 5.26 | -25.92 % | $ 113 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 67.13 | -4.11 % | $ 3.14 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 370.89 | -0.25 % | $ 30.9 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 101.65 | 0.63 % | $ 6.86 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 664.97 | -1.18 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 346.21 | -2.02 % | $ 17.2 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 750.2 | -0.69 % | $ 36.1 B | NYSE,SPB |  Schweiz |
 |
Danaher Corporation
DHR
|
$ 236.19 | 0.46 % | $ 168 B | NYSE,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 30.39 | -1.32 % | $ 28.8 B | NYSE | Niderland |
 |
RadNet
RDNT
|
$ 77.91 | -0.6 % | $ 5.86 B | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 10.05 | 2.55 % | $ 419 M | NYSE American | USA |
 |
Neuronetics
STIM
|
$ 2.01 | -7.8 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 719.09 | -0.35 % | $ 271 B | NYSE,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.